Examining its historical performance, the BMY stock has tended to react negatively after earnings announcements. Over the past five years, it posted a negative one-day return in 55% of cases ...

Bristol Myers Squibb stock (NYSE: BMY) has risen by 7% this year, outperforming the S&P 500 which has fallen by 1%. BMS’s robust Q4 performance has contributed to its positive momentum.

Investors looking for stocks in the Medical - Biomedical and Genetics sector might want to consider either Bristol Myers Squibb (BMY) or Vertex Pharmaceuticals (VRTX). But which of these two ...

Investors with an interest in Medical - Biomedical and Genetics stocks have likely encountered both Bristol Myers Squibb (BMY) and Vertex Pharmaceuticals (VRTX). But which of these two stocks ...

Below is Validea's guru fundamental report for BRISTOL-MYERS SQUIBB CO (BMY). Of the 22 guru strategies we follow, BMY rates highest using our P/B Growth Investor model based on the published ...

Key BMY program revenue is at risk from loss of patent exclusivity over the next several years. The company has turned to acquisitions to fortify its pipeline and revenue streams. BMY is relying ...

BMY will experience LOEs on a couple of key drugs during the mid-to-late 2020s. Current valuations more than account for that, however. The company is highly profitable and generates huge free ...

You may be called upon to rescue your friends and family, when that day comes (after tomorrow), you will want a miliatry surpluss vehicle like this BMY DIV of Harsco M923A2 5 ton, 6x6.

HARRISBURG, Pa. (AP) -- Industrial services company Harsco Corp. on Friday said its chief financial officer and treasurer resigned. Stephen Schnoor's departure was effective Friday. Harsco named ...